NorthWest Biotherapeutics Inc (NWBO)

[datafarer]

@ex - i agree and understand what was the original goal and what not. Let’s focus on current state after many years into this study - cross over resulted in 90% as opposed to only 66% subjects getting the vaccine per randomization of 2:1.

Now somebody comes and tells me, this study sample is doing really well compared to baseline. I say ok since majority of subjects got the intervention (remaining 10% could be driving it higher - possible but unlikely)

I stop and say well tell me more about representativeness of this sample (did you just happen to enroll young people, males, mgmt yada yada) once I ensure that that’s not the case, I am golden and I stop. If somehow, that’s not enough I look at the qualitative data ie compassionate use cases (although I would like to know more and entirety of all such cases)

If this vaccine didn’t do anything, I would not see better than baseline numbers for sample (blinded) So if I then go on to separate 10% of control and compare *well*, where do you think it would go up or down? I want to remind myself that they had 2 interim read outs of this study sample.

Lastly, to the point why ain’t people buying this stock. There’s no end to human/market folly. You yourself need convincing and hard facts of trial data which is great thing as “investor” and just may be everyone is waiting for that. As for others who jumped in, they may be doing it for various reasons ranging from being true believers to humanitarians to degenerates... you take a pick.